NHD Global
Growth Hormone & IGF · Source-reviewed dossier
Source-Reviewed Research Dossier
PEG-MGF is a catalog term for a PEGylated peptide associated with the IGF-1 Ec/mechano-growth-factor research lineage. Public literature provides little direct characterization of commercial PEG-MGF materials, so peptide sequence, PEG size, attachment site and distribution must be verified analytically.
Shared values below are consolidated from the current catalog record. They are not independent verification or lot results; the current product specification and lot COA control.
Product identity
Literature reference parameters
Identity safeguard Reference identifiers above describe the literature compound record. The supplied form, formula, molecular weight, purity and storage conditions must be verified against the product-specific specification and lot COA.
A target-to-pathway view grounded in the linked research records.
Reported research findings
Reported outcomes are paired with their experimental model and evidence boundary.
A 2026 review places PEG-MGF within the emerging GH/IGF-1 peptide landscape and documents the gap between evidence and self-administration claims.
Review-level discussion does not define a standardized PEG-MGF molecule.
Read the primary studyA 2023 analytical paper evaluated serum and enzymatic stability of multiple doping-peptide standards.
The study supports the need for analyte-specific characterization and does not validate PEG-MGF.
Read the primary studyCatalog options
Pack-level catalog data; lot-level controls remain document-specific.
Single-component peptide · 2 mg/vial nominal · 10-vial pack · supplied form and release limits controlled by lot specification.
Request by lot: CoA, HPLC purity and MS identity
Document availability is stated honestly and can vary by catalog variant or lot.
Analytical interpretation
Use the source-reviewed guide to separate chromatographic area purity, quantitative assay, LC-MS identity, composition and stability evidence before comparing variants or requesting a lot record.
Open the Quality & Documentation HubHPLC area ≠ assayA dominant peak does not establish target mass fraction.
Intact mass ≠ full sequenceIdentity strength depends on resolution and orthogonal evidence.
Counterions affect contentWater, salt form and solvents change the as-is composition.
Storage needs a data basisShipping practice is not the same as stability evidence.
Evidence map
Published studies and regulatory records, not customer testimonials or usage guidance.
Review-level discussion does not define a standardized PEG-MGF molecule.
View primary recordThe study supports the need for analyte-specific characterization and does not validate PEG-MGF.
View primary recordThird-party publications selected for direct relevance.
Critical review. 2026. PMID 42395176.
Analytical study. 2023. PMID 37688464.
Concise answers for researchers comparing identity, evidence and catalog variants.
PEG-MGF is a catalog term for a PEGylated peptide associated with the IGF-1 Ec/mechano-growth-factor research lineage. Public literature provides little direct characterization of commercial PEG-MGF materials, so peptide sequence, PEG size, attachment site and distribution must be verified analytically.
Direct peer-reviewed evidence is sparse; current publications mainly discuss detection, stability or the broader performance-enhancing-peptide landscape.
No. The cited records describe their own intervention, formulation, model and controls. They do not verify the identity, purity, sterility, safety or efficacy of a catalog lot.
A lot-specific COA, product specification sheet and analytical method summary can be requested where applicable.
Store at -20 °C, protected from light and moisture. After reconstitution, aliquot and avoid repeated freeze-thaw cycles. Confirm the applicable storage statement on the product-specific specification and lot documentation.
Knowledge center
Owned educational content connected to this family.
Direct evidence for a defined covalently PEGylated MGF product is sparse. Several frequently cited papers instead placed native MGF peptide inside PEGDMA hydrogel devices—a…
Updated September 8, 2026
“PEG-MGF” is not a complete molecular identity. A defensible material record must define the peptide, PEG architecture, attachment chemistry, site distribution and unmodified-peptide fraction.
Updated September 8, 2026Knowledge tools
Move from this dossier into canonical evidence maps, verified status records, analytical interpretation and laboratory calculations.
Claims were checked against the linked primary publication, regulatory label or authoritative compound record. Published findings stay attached to their study model, formulation and route. Catalog identity and lot quality remain controlled by the applicable specification and lot-specific documents.
Technical procurement
Selected: FMP2 · 2 mg × 10 vials
Tell us what you need. Your enquiry will be routed to the appropriate contact for catalog numbers, availability and quotation details.
